Sign inGet started

Alva Emily Peterson

Insider CIK 1738422 · ALKS Director · AMRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AMRX Amneal Pharmaceuticals, In A Award deriv2025-05-062025-05-0834,819— $034,819SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2025-05-052025-05-0840,258— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2025-05-052025-05-0840,258— $0211,029SEC↗
AMRX Amneal Pharmaceuticals, In S Sale2025-03-052025-03-0780,000$8.90 $712.0K170,771SEC↗
ALKS Alkermes plc. M Exercise deriv2024-06-292024-07-016,104— $00SEC↗
ALKS Alkermes plc. F Tax w/h2024-06-292024-07-011,465$24.10 $35.3K27,302SEC↗
ALKS Alkermes plc. M Exercise2024-06-292024-07-016,104— $028,767SEC↗
ALKS Alkermes plc. M Exercise deriv2024-06-092024-06-103,871— $00SEC↗
ALKS Alkermes plc. M Exercise2024-06-092024-06-103,871— $023,593SEC↗
ALKS Alkermes plc. F Tax w/h2024-06-092024-06-10930$23.91 $22.2K22,663SEC↗
ALKS Alkermes plc. A Award deriv2024-05-312024-06-0417,492— $017,492SEC↗
ALKS Alkermes plc. A Award deriv2024-05-312024-06-048,013— $08,013SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2024-05-102024-05-1476,453— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2024-05-102024-05-1476,453— $0250,771SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2024-05-022024-05-0640,258— $040,258SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-04119— $06,104SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-04254$30.72 $7.8K12,986SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-04231$30.86 $7.1K11,785SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-04313$24.24 $7.6K15,990SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-04455$24.22 $11.0K23,214SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-0422$24.22 $5331,137SEC↗
ALKS Alkermes plc. J Other deriv2023-11-172024-06-0475— $03,871SEC↗
ALKS Alkermes plc. M Exercise deriv2023-07-072023-07-105,957— $00SEC↗
ALKS Alkermes plc. F Tax w/h2023-07-072023-07-101,430$29.88 $42.7K19,722SEC↗
ALKS Alkermes plc. M Exercise2023-07-072023-07-105,957— $021,152SEC↗
ALKS Alkermes plc. A Award deriv2023-06-292023-06-3012,732— $012,732SEC↗
ALKS Alkermes plc. A Award deriv2023-06-292023-06-305,985— $05,985SEC↗
ALKS Alkermes plc. M Exercise deriv2023-06-092023-06-123,795— $03,796SEC↗
ALKS Alkermes plc. F Tax w/h2023-06-092023-06-12911$31.13 $28.4K15,195SEC↗
ALKS Alkermes plc. M Exercise2023-06-092023-06-123,795— $016,106SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2023-05-102023-05-1180,128— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2023-05-102023-05-1180,128— $0174,318SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2023-05-092023-05-1176,453— $076,453SEC↗
ALKS Alkermes plc. A Award deriv2022-07-072022-07-085,957— $05,957SEC↗
ALKS Alkermes plc. A Award deriv2022-07-072022-07-0811,554— $011,554SEC↗
ALKS Alkermes plc. M Exercise deriv2022-06-142022-06-167,585— $00SEC↗
ALKS Alkermes plc. M Exercise2022-06-142022-06-167,585— $013,216SEC↗
ALKS Alkermes plc. F Tax w/h2022-06-142022-06-16905$27.19 $24.6K12,311SEC↗
ALKS Alkermes plc. M Exercise deriv2022-06-092022-06-10532— $00SEC↗
ALKS Alkermes plc. M Exercise deriv2022-06-092022-06-103,796— $07,591SEC↗
ALKS Alkermes plc. M Exercise2022-06-092022-06-103,796— $05,935SEC↗
ALKS Alkermes plc. M Exercise2022-06-092022-06-10532— $02,182SEC↗
ALKS Alkermes plc. F Tax w/h2022-06-092022-06-1043$28.13 $1.2K2,139SEC↗
ALKS Alkermes plc. F Tax w/h2022-06-092022-06-10304$28.13 $8.6K5,631SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2022-05-092022-05-1080,128— $080,128SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2022-05-082022-05-1035,406— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2022-05-082022-05-1035,406— $094,190SEC↗
ALKS Alkermes plc. P Buy2021-08-232021-08-241,650$30.22 $49.9K1,650SEC↗
ALKS Alkermes plc. A Award deriv2021-06-142021-06-167,585— $07,585SEC↗
ALKS Alkermes plc. A Award deriv2021-06-142021-06-1615,677— $015,677SEC↗
ALKS Alkermes plc. A Award deriv2021-06-092021-06-11532— $0532SEC↗
ALKS Alkermes plc. A Award deriv2021-06-092021-06-1122,759— $022,759SEC↗
ALKS Alkermes plc. A Award deriv2021-06-092021-06-1111,387— $011,387SEC↗
ALKS Alkermes plc. A Award deriv2021-06-092021-06-111,115— $01,115SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2021-05-062021-05-0746,218— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2021-05-062021-05-0746,218— $058,784SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2021-05-052021-05-0735,406— $035,406SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2020-05-072020-05-076,459— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2020-05-072020-05-076,459— $012,566SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2020-05-052020-05-0746,218— $046,218SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise deriv2019-05-082019-05-086,107— $00SEC↗
AMRX Amneal Pharmaceuticals, In M Exercise2019-05-082019-05-086,107— $06,107SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2019-05-062019-05-0828,044— $028,044SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2019-05-062019-05-086,459— $06,459SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2018-05-072018-05-0924,977— $024,977SEC↗
AMRX Amneal Pharmaceuticals, In A Award deriv2018-05-072018-05-096,107— $06,107SEC↗